{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:48:13Z","timestamp":1760014093717},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jpsychires.2003.10.005","type":"journal-article","created":{"date-parts":[[2004,1,17]],"date-time":"2004-01-17T05:15:06Z","timestamp":1074316506000},"page":"259-265","source":"Crossref","is-referenced-by-count":7,"title":["Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Jay D.","family":"Amsterdam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Brunswick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gibertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2003.10.005_BIB1","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1097\/00004714-199006001-00004","article-title":"Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies","volume":"10","author":"Blier","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2003.10.005_BIB2","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/00005344-199001001-00006","article-title":"Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists","volume":"15","author":"Blier","year":"1990","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2003.10.005_BIB4","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199006001-00002","article-title":"Azapirones: history of development","volume":"10","author":"Eison","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB5","first-page":"659","article-title":"A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression","volume":"32","author":"Feiger","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2165\/00023210-199401050-00009","article-title":"Gepirone in depression and anxiety disorders","volume":"1","author":"Fitton","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB7","series-title":"ECDEU Assessment manual for psychopharmacology: publication ADM 76-338","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00023210-199810050-00004","article-title":"Serotonin 5-HT1A receptor agonists as antidepressants: pharmacological rationale and evidence for efficacy","volume":"10","author":"Heiser","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.280.19.1665","article-title":"Maintenance phase efficacy of sertraline for chronic depression. A randomized controlled trial","volume":"280","author":"Keller","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB11","series-title":"Clinical evaluation of psychotropic drugs: principles and guidelines","first-page":"281","article-title":"Evaluating drug treatments of depressive disorders","author":"Klerman","year":"1994"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(01)01011-1","article-title":"5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential","volume":"420","author":"Koek","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB13","first-page":"24","article-title":"Behavioral studies of serotonin receptor agonists as antidepressant drugs","volume":"52","author":"Lucki","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-199410000-00011","article-title":"Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement","volume":"14","author":"McGrath","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4088\/JCP.v62n1006","article-title":"Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients","volume":"62","author":"Thase","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2003.10.005_BIB16","first-page":"335","article-title":"A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients","volume":"32","author":"Wilcox","year":"1996","journal-title":"Psychopharmacology Bulletin"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395603001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395603001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T09:51:47Z","timestamp":1550224307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395603001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022395603001390"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2003.10.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}